SACRAL NERVE STIMULATION IN PATIENTS WITH CHRONIC INTRACTABLE PELVIC PAIN

No AccessJournal of UrologyCLINICAL UROLOGY: Original Articles1 Nov 2001SACRAL NERVE STIMULATION IN PATIENTS WITH CHRONIC INTRACTABLE PELVIC PAIN STEVEN SIEGEL, ELISABETH PASZKIEWICZ, CHARLENE KIRKPATRICK, BEVERLY HINKEL, and KIMBERLY OLESON STEVEN SIEGELSTEVEN SIEGEL More articles by this author , ELISABETH PASZKIEWICZELISABETH PASZKIEWICZ More articles by this author , CHARLENE KIRKPATRICKCHARLENE KIRKPATRICK More articles by this author , BEVERLY HINKELBEVERLY HINKEL More articles by this author , and KIMBERLY OLESONKIMBERLY OLESON More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(05)65665-0AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: Transforamenal sacral nerve stimulation with an implantable neuroprosthetic device has been shown to benefit patients with chronic voiding dysfunction. In this study we measured the effectiveness of sacral nerve stimulation in 10 patients with chronic intractable pelvic pain. Materials and Methods: After successful percutaneous trial stimulation, a neuroprosthetic sacral nerve stimulation device was surgically implanted in 10 patients with chronic intractable pelvic pain. Leads were placed in the S3 and S4 foramen in 8 and 2 cases, respectively. Patients were evaluated throughout the study using a patient pain assessment questionnaire on a scale of 0—absent to 5—excruciating pain. Pain was assessed at baseline, during test stimulation, and 1, 3 and 6 months after surgical lead implantation. An additional long-term assessment was done at a median followup of 19 months. Results: Of the 10 patients with the implant 9 had a decrease in the severity of the worst pain compared to baseline at a median followup of 19 months. The number of hours of pain decreased from 13.1 to 6.9 at the same followup interval. There was also an average decrease in the rate of pain from 9.7 at baseline to 4.4 on a scale of 10—always to 0—never having pain. At a median of 19 months 6 of 10 patients reported significant improvement in pelvic pain symptomology. Conclusions: These data imply that transforamenal sacral nerve stimulation can have beneficial effects on the severity and frequency of chronic intractable pelvic pain. Future clinical studies are necessary to determine the long-term effectiveness of this therapy. References 1 : Sacral nerve stimulation for treatment of refractory urinary urge incontinence. Sacral Nerve Stimulation Study Group. J Urol1999; 162: 352. Link, Google Scholar 2 : Sacral neuromodulation in the treatment of urgency-frequency symptoms: a multicenter study on efficacy and safety. J Urol2000; 163: 1849. Link, Google Scholar 3 : Sacral root neuromodulation in the treatment of various voiding and storage problems. Int Urogynecol J Pelvic Floor Dysfunct1999; 10: 336. Google Scholar 4 : Neuromodulation of voiding dysfunction and pelvic pain. World J Urol1991; 9: 138. Crossref, Google Scholar 5 : Management of voiding dysfunction with an implantable neuroprosthesis. Urol Clin North Am1992; 19: 163. Medline, Google Scholar 6 : Chronic pelvic pain: prevalence, health-related quality of life, and economic correlates. Obstet Gynecol1996; 87: 321. Google Scholar 7 : Chronic pelvic pain. Obstet Gynecol1993; 5: 740. Google Scholar 8 : Chronic pelvic pain. Am Fam Physician1996; 54: 2225. Google Scholar 9 : Factors influencing outcome in consultations for chronic pelvic pain. J Womens Health1998; 7: 1041. Google Scholar 10 : Surgical treatment for chronic pelvic pain. JSLS1998; 2: 129. Google Scholar 11 : Chronic pelvic pain. In: . Edited by . Boca Raton: St. Lucie Press1998: 525. Google Scholar 12 : Epidural spinal cord stimulation for treatment of chronic pain: some predictors of success. A 15-year experience. Surg Neurol1998; 50: 110. Google Scholar 13 : Improving neuromodulation techniques for refractory voiding dysfunctions: two-stage implant. Urology1997; 49: 358. Google Scholar 14 : Sacral nerve stimulation results may be improved by electrodiagnostic techniques. Int Urogynecol J Pelvic Floor Dysfunct2000; 11: 352. Google Scholar From the Metropolitan Urologic Specialists, St. Paul and Medtronic Functional Stimulation Therapies, Minneapolis, Minnesota© 2001 by American Urological Association, Inc.FiguresReferencesRelatedDetailsCited byMarcelissen T, Jacobs R, van Kerrebroeck P and de Wachter S (2011) Sacral Neuromodulation as a Treatment for Chronic Pelvic PainJournal of Urology, VOL. 186, NO. 2, (387-393), Online publication date: 1-Aug-2011.Wein A (2009) Voiding Function and Dysfunction, Bladder Physiology and Pharmacology, and Female UrologyJournal of Urology, VOL. 183, NO. 2, (570-570), Online publication date: 1-Feb-2010.Groen J, Ruud Bosch J and van Mastrigt R (2018) Sacral Neuromodulation in Women With Idiopathic Detrusor Overactivity Incontinence: Decreased Overactivity but Unchanged Bladder Contraction Strength and Urethral Resistance During VoidingJournal of Urology, VOL. 175, NO. 3, (1005-1009), Online publication date: 1-Mar-2006.JOHN H, RÜEDI C, KÖTTING S, SCHMID D, FATZER M and HAURI D (2018) A New High Frequency Electrostimulation Device to Treat Chronic ProstatitisJournal of Urology, VOL. 170, NO. 4 Part 1, (1275-1277), Online publication date: 1-Oct-2003. Volume 166Issue 5November 2001Page: 1742-1745 Advertisement Copyright & Permissions© 2001 by American Urological Association, Inc.Keywordsprostheses and implantssacrumpelvic painurination disorderselectric stimulationMetricsAuthor Information STEVEN SIEGEL More articles by this author ELISABETH PASZKIEWICZ More articles by this author CHARLENE KIRKPATRICK More articles by this author BEVERLY HINKEL More articles by this author KIMBERLY OLESON More articles by this author Expand All Advertisement PDF downloadLoading ...